PVALB and schizophrenia: It has been suggested that NMDA receptor hypofunction and alterations in the parvalbumin-positive interneurons are involved in schizophrenia in mice (Lodge et al. 2009) and in humans (Gonzalez-Burgos and Lewis 2012), but PPI was not measured in these studies.